Rocket Lab (RKLB) is trading at $59.05 after a modest 24-hour decline, with price still sitting above its 20-day average and inside a broader recovery pattern. The latest quarterly update showed re...
Rocket Lab (RKLB) is being priced off a stronger fundamental backdrop than a few weeks ago. On November 9, the company said third-quarter 2026 revenue hit a record level, backlog grew to $1.2 billion, it generated positive GAAP operating cash flow, and it guided to record revenue and gross margin expansion in Q4 2026. That matters because it shifts the story from a pure execution trade to one with visible operating momentum and a larger order base behind it.
The market has not ignored that update. Yahoo Finance showed RKLB at $61.53 on November 13, while the supplied market data now puts it at $59.05, down 0.81% over 24 hours. The move looks more like digestion than a full reset: the stock is still above the 20-day average of $56.56 and the Bollinger midline sits in the same area.
Analyst coverage supplied here remains constructive. 00, and a latest Morgan Stanley rating action on November 11 that maintained Overweight while cutting the target from $105 to $103. TipRanks also cited Morgan Stanley’s Kristine Liwag as Overweight with a $103 target, framing the post-earnings move as a reaction to the company’s latest results and contract backlog. 34.
Source link







